Unlearn.AI

AI-driven digital twins for faster clinical trials.

Edited:

πŸ“‹ Overview of Unlearn.AI

Founding Year

2017

Estimated Funding

$0000

Size

$0000

Locations

San Francisco

Primary Industry

Biotechnology

πŸ“™ About Unlearn.AI

Unlearn.AI offers clinical trials by using digital twinsβ€”AI-generated models that predict a patient’s health outcomes. These digital twins reduce the number of participants needed, shortening enrollment time, and increasing the power of early-stage studies. It helps researchers make faster, more confident decisions in areas like neuroscience, immunology, and metabolic diseases.

πŸ’° Recent Investors of Unlearn.AI

Altimeter Capital Management, Insight Partners, Investor

Β© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.